Literature DB >> 24768416

The influence of axillary reverse mapping related factors on lymphedema in breast cancer patients.

K Ikeda1, Y Ogawa2, C Kajino2, S Deguchi3, S Kurihara3, T Tashima3, W Goto3, Y Nishiguchi3, S Tokunaga4, H Fukushima5, T Inoue5.   

Abstract

PURPOSE: Upper extremity lymphedema (LE) is a harmful breast cancer complication. It has been reported that patient- or treatment-related risk factors of LE. Axillary reverse mapping (ARM) has been performed to prevent LE during axillary lymph node dissection (ALND) by visualizing the upper extremity lymphatics. We investigated whether ARM related factors included novel predictive risk factors of LE.
METHODS: ARM revealed fluorescent axillary nodes (ARM nodes) in 76 patients by fluorescence imaging. Only ARM nodes within the ALND field were removed. Twenty-four (32%) patients developed LE (LE+) and 52 did not (LE-) during a median 24-month post-surgical follow-up period. We retrospectively evaluated the clinical features and ARM factors of LE+ and LE-.
RESULTS: The positive ARM node rate among LE+ was 42%, significantly greater frequency than that among LE- (13%: p ≤ 0.05). Cranial collectors (lymphatic ducts along or above the axillary vein) were significantly more frequent in LE- (44%) than in LE+ (21%: p ≤ 0.05). Multivariate analysis revealed postoperative radiation and positive ARM nodes to be positive risk factors and cranial collectors to be a negative risk factor of LE.
CONCLUSIONS: ARM factors could predict the incidence of LE post-axillary surgeries in breast cancer patients.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Axillary reverse mapping; Breast cancer; Fluorescence imaging; Lymphedema; Predictive factor

Mesh:

Year:  2014        PMID: 24768416     DOI: 10.1016/j.ejso.2014.03.023

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  8 in total

1.  Lymph nodes behind the axillary neurovascular bundle: case report and cadaveric study of frequency and distribution.

Authors:  Nebojsa Ivanovic; Darko Zdravkovic; Miroslav Granic; Biljana Sredic; Natasa Colakovic; Miodrag Stojiljkovic
Journal:  Surg Radiol Anat       Date:  2015-06-22       Impact factor: 1.246

Review 2.  Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments.

Authors:  Tessa C Gillespie; Hoda E Sayegh; Cheryl L Brunelle; Kayla M Daniell; Alphonse G Taghian
Journal:  Gland Surg       Date:  2018-08

3.  Evaluation of Relative Abundance of Lymphedema after Reverse Axillary Mapping in Patients with Breast Cancer.

Authors:  Reza Eshraghi Samani; Hossein Ebrahimi; Aryan Rafiee Zadeh; Masoumeh Safaee
Journal:  Adv Biomed Res       Date:  2022-04-29

4.  Evaluation of kinesthetic sense and hand function in women with breast cancer-related lymphedema.

Authors:  Didem Karadibak; Tugba Yavuzsen
Journal:  J Phys Ther Sci       Date:  2015-06-30

Review 5.  The Feasibility and Oncological Safety of Axillary Reverse Mapping in Patients with Breast Cancer: A Systematic Review and Meta-Analysis of Prospective Studies.

Authors:  Chao Han; Ben Yang; Wen-Shu Zuo; Gang Zheng; Li Yang; Mei-Zhu Zheng
Journal:  PLoS One       Date:  2016-02-26       Impact factor: 3.240

Review 6.  New classifications of axillary lymph nodes and their anatomical-clinical correlations in breast surgery.

Authors:  Roberto Cirocchi; Maria Ida Amabile; Alessandro De Luca; Federico Frusone; Domenico Tripodi; Patrizia Gentile; Renata Tabola; Daniele Pironi; Flavio Forte; Massimo Monti; Vito D'Andrea; Salvatore Sorrenti
Journal:  World J Surg Oncol       Date:  2021-03-29       Impact factor: 2.754

Review 7.  Lymphoedema After Breast Cancer Treatment is Associated With Higher Body Mass Index: A Systematic Review and Meta-Analysis.

Authors:  Astère Manirakiza; Laurent Irakoze; Lin Shui; Sébastien Manirakiza; Louis Ngendahayo
Journal:  East Afr Health Res J       Date:  2019-11-29

8.  Clinical application of axillary reverse mapping in patients with breast cancer: A systematic review and meta-analysis.

Authors:  Wilson A Wijaya; Jing Peng; Yinhai He; Junjie Chen; Ying Cen
Journal:  Breast       Date:  2020-08-18       Impact factor: 4.380

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.